Crossref
Dupilumab for Bullous Pemphigoid: To Treat or Not to Treat?
Cutis · 01.04.2026 · 4 (117)
DOI: 10.12788/cutis.1378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cutis, erschienen am 01.04.2026. Verfasst von Alexandra R Matarazzo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton.
Zitieren
APA
Matarazzo, A. R., Molle, A., & Hennekens, C. H. (2026). Dupilumab for Bullous Pemphigoid: To Treat or Not to Treat?. Cutis, 4(117). https://doi.org/10.12788/cutis.1378
Vancouver
Matarazzo AR, Molle A, Hennekens CH. Dupilumab for Bullous Pemphigoid: To Treat or Not to Treat?. Cutis. 2026;4(117). doi:10.12788/cutis.1378
BibTeX
@article{Matarazzo2026,
author = {Matarazzo, Alexandra R and Molle, Anthony and Hennekens, Charles H},
title = {Dupilumab for Bullous Pemphigoid: To Treat or Not to Treat?},
journal = {Cutis},
year = {2026},
volume = {4},
number = {117},
doi = {10.12788/cutis.1378}
}
EUVIMED